Tag: Hospital-Acquired Pneumonia (HAP) Drugs Market

Hospital-Acquired Pneumonia (HAP) Drugs Market Drivers And Trends Hospital-Acquired Pneumonia (HAP) Drugs Market size was valued at USD 2.85 Billion in 2022 and is projected to reach USD 4.45 Billion by 2030, growing at a CAGR of 5.6% from 2024 to 2030. The increasing prevalence of hospital-acquired infections, along with rising incidences of multi-drug resistant […]